Om Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
HovedkontorCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Grunnlagt2013
StatusAktiv
Patenter60 patenter
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Logg inn for å se alle 60 patentene
Bla gjennom hele patentporteføljen med publiseringsnumre, datoer og familier.
Logg inn Opprett en konto med e-postadressen dinDet er gratis
Ved å fortsette godtar du Heelkys brukeravtale, personvernerklæring og retningslinjer for informasjonskapsler.
Vurderinger
Ingen anmeldelser ennå. Har du jobbet med Onyx Pharmaceuticals, Inc.? Bli den første som deler erfaringen din.
Juridisk informasjon
| Juridisk navn | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Se på GLEIF ↗ |
| Registrert adresse | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Aktiv |
Kilder: GLEIF · oppdatert 16. Oktober 2026
Kontakt og lenker
Sted
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Er dette selskapet ditt?
Krev denne siden gratis for å legge til logo, produkter, bilder og jobber, og for å svare på anmeldelser.
Krev denne sidenBli med i Heelky for å koble til, ansette og vokse
Opprett en gratis konto for å sende meldinger, søke på jobber og legge ut oppdrag.
Bli med nå — det er gratis